Literature DB >> 28630239

An unusual case of Escherichia coli O157:H7 infection with pseudomembranous colitis-like lesions associated with haemolytic-uraemic syndrome and neurological sequelae.

James Kennedy1, Lauren Simmonds2, Robert Orme2, Warren Doherty2.   

Abstract

A 75-year-old man was admitted with abdominal pain and fresh rectal bleeding. Significantly, he had no risk factors for Clostridium difficile infection. An abdominal CT demonstrated colonic thickening, and flexible sigmoidoscopy identified pseudomembranous colitis-like lesions. After initial treatment as C. difficile colitis, a stool sample revealed Escherichia coli O157:H7 infection. Antibiotic therapy was stopped due to the risk of lysis-mediated toxin release, but unfortunately, the patient continued to deteriorate. He developed several of the severe sequelae of E. coli O157:H7 infection, including haemolytic-uraemic syndrome with an acute kidney injury necessitating haemofiltration, plus progressively severe seizures requiring escalating antiepileptic treatment and intubation for airway protection. After a prolonged intensive care admission and subsequent recovery on the ward, our patient was discharged alive. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute renal failure; endoscopy; epilepsy and seizures; infection (gastroenterology)

Mesh:

Substances:

Year:  2017        PMID: 28630239      PMCID: PMC5534687          DOI: 10.1136/bcr-2016-218586

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Clostridioides difficile co-infection with Enterohemorrhagic Escherichia coli (EHEC)-a potentially fatal combination.

Authors:  Farah Deshmukh; Upasana Agrawal; Nancy Merrell
Journal:  IDCases       Date:  2020-05-08

2.  Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children.

Authors:  Jun Huang; Guangming Chen; Liqiang Ma; Ting Tan
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.